Public Notice — Orlando, Florida

---------------------------------------------
PUBLIC NOTICE
Let it be known to one and all that in the United States of America and the World that on this date of April 18, 2026, the date of our Lord: that The American Osteopathic Association of Prolotherapy Regenerative Medicine, located in Delaware, USA, bestowed the Honors of Successful competition of all the Certifications of Attendance of Completion of the full study course work which included the Didactics and Clinical Hands on Clinical Applications of the entire program of the Annual Spring 2026 Prolotherapy Conference in Orlando, Florida to: Michael John Badanek, DC, NMD, DACBN, CNS, DCBCN, D(MM), MD(h), C.T.T.P., MSGR/CHEV., residing in the State of Florida in the United States of America.
This intensive study offered by this official Osteopathic Association of Prolotherapy Regenerative Medicine covered both the Didactic and Clinical Hands-on Clinical Applications of Injectable Therapeutics of Prolotherapy, Platelet-Rich-Plasma infusions and Injections of all extremities and spine, Neural Therapy evaluation and Injections of the spine and all body visceral regions and extremities, Ultrasound Guided Prolotherapy Injections of the spine and all joints of both upper and lower extremities, Osteopathic Manipulative Therapy and Prolotherapy Emergencies: Recognition and Office-Based Management skills, to name a few of the many programs offered in this symposium’s meeting.
The Hands-on Clinical teaching techniques encompassed the modalities of administering multiple products described as Vitamins, Minerals, Homeopathic Solutions, Procaine, Lidocaine, Platelet-Rich Plasma (PRP), various other Medications and Compounds through the techniques of Intravenous, intramuscular, Subcutaneous, Intra-articular, oral, Nasal and lnfraspinous and all other routes of administration.
Michael John Badanek, successfully attended and completed ALL Administrative Clinical Hands-on Techniques and Didactic Academic Studies during this program to be able to be bestowed the Post Graduate Doctoral Degree and Certification of Completion in this Annual Prolotherapy Conference offered in Orlando, Florida (April 16 thru 18, 2026).
Therefore, let it be known to one and all, that from this date of April 18, 2026 and forth in Perpetual time that Michael John Badanek DC, NMD, DACBN, CNS, DCBCN, D(MM), MD(h), C.T.T.P., MSGR/CHEV., HAS BEEN SUCCESSFULLY EDUCATED BOTH IN THE Didactic and Physical Hands-On training and application of any and All Injectable Therapeutics and is HIGHLY QUALIFIED in the treatment and administration of any and all injectable Therapeutics IN ANY CLINICAL SETTING AND LOCATION(S) THROUGHOUT THE UNITED STATES OF AMERICA AND THE WORLD for the clinical care of the sick and health challenged.
Therefore noted: On this 18th day of April, Two-Thousand Twenty-Six: That Michael John Badanek DC, NMD, DACBN, CNS, DCBCN, D(MM), MD(h), C.T.T.P., MSGR/CHEV., has Successfully met and completed all the Requirements of The Annual Spring 2026 Prolotherapy Conference Offered in Orlando, Florida (April 16-18, 2026).
Aline Fournier, D.O. MPH
Program Chairman,
AOAPRM, Inc.
Linda Pavina:
Executive Director,
AOAPRM, INC.
May 7, 14, 21, 28, 2026 34-4tc
---------------------------------------------